Shou-Ching Jaminet

916 total citations
16 papers, 604 citations indexed

About

Shou-Ching Jaminet is a scholar working on Molecular Biology, Immunology and Allergy and Cell Biology. According to data from OpenAlex, Shou-Ching Jaminet has authored 16 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Immunology and Allergy and 4 papers in Cell Biology. Recurrent topics in Shou-Ching Jaminet's work include Angiogenesis and VEGF in Cancer (6 papers), Cell Adhesion Molecules Research (5 papers) and Platelet Disorders and Treatments (3 papers). Shou-Ching Jaminet is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Cell Adhesion Molecules Research (5 papers) and Platelet Disorders and Treatments (3 papers). Shou-Ching Jaminet collaborates with scholars based in United States, China and Japan. Shou-Ching Jaminet's co-authors include Juan M. Melero‐Martin, Arin K. Greene, Rafael Moreno‐Luna, Ruei‐Zeng Lin, Harold F. Dvorak, Shugeng Cao, Donald R. Senger, Dan Li, Dan Li and Ann M. Dvořàk and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Shou-Ching Jaminet

15 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shou-Ching Jaminet United States 12 349 107 94 83 63 16 604
Fei Zhu China 13 261 0.7× 115 1.1× 115 1.2× 116 1.4× 56 0.9× 21 782
Minghao Qu China 7 297 0.9× 121 1.1× 91 1.0× 36 0.4× 45 0.7× 8 742
Weiyuan Gong China 7 297 0.9× 121 1.1× 91 1.0× 36 0.4× 44 0.7× 10 745
Simona Pompili Italy 18 376 1.1× 126 1.2× 175 1.9× 73 0.9× 44 0.7× 33 836
Siru Zhou China 18 616 1.8× 237 2.2× 110 1.2× 57 0.7× 71 1.1× 42 1.1k
Gyuseok Lee South Korea 9 313 0.9× 181 1.7× 97 1.0× 35 0.4× 38 0.6× 15 803
Céline Deroyer Belgium 11 387 1.1× 229 2.1× 78 0.8× 32 0.4× 76 1.2× 23 890
Jianlin Zhou China 15 265 0.8× 107 1.0× 104 1.1× 45 0.5× 62 1.0× 33 685
Peijian Tong China 19 443 1.3× 144 1.3× 95 1.0× 55 0.7× 38 0.6× 55 868

Countries citing papers authored by Shou-Ching Jaminet

Since Specialization
Citations

This map shows the geographic impact of Shou-Ching Jaminet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shou-Ching Jaminet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shou-Ching Jaminet more than expected).

Fields of papers citing papers by Shou-Ching Jaminet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shou-Ching Jaminet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shou-Ching Jaminet. The network helps show where Shou-Ching Jaminet may publish in the future.

Co-authorship network of co-authors of Shou-Ching Jaminet

This figure shows the co-authorship network connecting the top 25 collaborators of Shou-Ching Jaminet. A scholar is included among the top collaborators of Shou-Ching Jaminet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shou-Ching Jaminet. Shou-Ching Jaminet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jaminet, Shou-Ching, et al.. (2025). AGX101: A TM4SF1-directed tubulin inhibitor conjugate in ongoing first-in-human trial including GI cancers.. Journal of Clinical Oncology. 43(4_suppl). 829–829. 1 indexed citations
2.
Lin, Chi‐Iou, et al.. (2024). TM4SF1 is a molecular facilitator that distributes cargo proteins intracellularly in endothelial cells in support of blood vessel formation. Journal of Cell Communication and Signaling. 18(2). e12031–e12031. 1 indexed citations
3.
Lin, Chi‐Iou, et al.. (2024). Transmembrane-4 L-Six Family Member-1 Is Essential for Embryonic Blood Vessel Development. Current Issues in Molecular Biology. 46(11). 13105–13118.
4.
Sitohy, Basel, Sung-Hee Chang, Tracey Sciuto, et al.. (2017). Early Actions of Anti–Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels. American Journal Of Pathology. 187(10). 2337–2347. 19 indexed citations
5.
Senger, Donald R., Dan Li, Shou-Ching Jaminet, & Shugeng Cao. (2016). Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet. PLoS ONE. 11(2). e0148042–e0148042. 93 indexed citations
6.
Sciuto, Tracey, Chi‐Iou Lin, Douglas S. Richardson, et al.. (2015). Intracellular distribution of TM4SF1 and internalization of TM4SF1-antibody complex in vascular endothelial cells. Biochemical and Biophysical Research Communications. 465(3). 338–343. 12 indexed citations
7.
Kaunisto, Aura, Whitney S. Henry, Laleh Montaser‐Kouhsari, et al.. (2015). NFAT1 promotes intratumoral neutrophil infiltration by regulating IL8 expression in breast cancer. Molecular Oncology. 9(6). 1140–1154. 35 indexed citations
8.
Lin, Chi‐Iou, Tracey Sciuto, Dan Li, et al.. (2014). TM4SF1: a new vascular therapeutic target in cancer. Angiogenesis. 17(4). 897–907. 38 indexed citations
9.
Lin, Chi‐Iou, et al.. (2014). Nanopodia - Thin, Fragile Membrane Projections with Roles in Cell Movement and Intercellular Interactions. Journal of Visualized Experiments. 12 indexed citations
10.
Lin, Ruei‐Zeng, Rafael Moreno‐Luna, Dan Li, et al.. (2014). Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling. Proceedings of the National Academy of Sciences. 111(28). 10137–10142. 129 indexed citations
11.
Lin, Chi‐Iou, et al.. (2014). Nanopodia - Thin, Fragile Membrane Projections with Roles in Cell Movement and Intercellular Interactions. Journal of Visualized Experiments. 2 indexed citations
12.
Abid, M. Ruhul, Lei Yuan, David Beeler, et al.. (2014). FOXO1-Mediated Activation of Akt Plays a Critical Role in Vascular Homeostasis. Circulation Research. 115(2). 238–251. 78 indexed citations
13.
Lin, Ruei‐Zeng, Rafael Moreno‐Luna, Rocío Múñoz‐Hernández, et al.. (2013). Human white adipose tissue vasculature contains endothelial colony-forming cells with robust in vivo vasculogenic potential. Angiogenesis. 16(4). 735–744. 60 indexed citations
14.
Yuan, Lei, Lauren Janes, David Beeler, et al.. (2013). Role of RNA splicing in mediating lineage-specific expression of the von Willebrand factor gene in the endothelium. Blood. 121(21). 4404–4412. 15 indexed citations
15.
Li, Dan, Lay‐Hong Ang, Tracey Sciuto, et al.. (2011). TM4SF1: a tetraspanin-like protein necessary for nanopodia formation and endothelial cell migration. Angiogenesis. 14(3). 345–354. 48 indexed citations
16.
Sitohy, Basel, Janice A. Nagy, Shou-Ching Jaminet, & Harold F. Dvorak. (2011). Tumor-Surrogate Blood Vessel Subtypes Exhibit Differential Susceptibility to Anti-VEGF Therapy. Cancer Research. 71(22). 7021–7028. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026